期刊文献+

树突状细胞诱导的细胞毒性T细胞对黑色素瘤的抑制作用

Inhibitory effects of cytotoxic T lymphocyte induced by dendritic cells on melanoma
原文传递
导出
摘要 目的探讨CIM^+CD25^+Treg细胞对树突状细胞(DC)诱导的细胞毒性T细胞(CTL)对B16黑色素瘤抑瘤作用的影响及其机制。方法制备C57BL/6小鼠B16黑色素瘤动物模型,行全身放疗达非髓性淋巴细胞删除(NMLD)状态。随机将80只小鼠分为4组。A组:在DC与T细胞共同培养前应用免疫磁珠法(MACS)删除CIM^+CD25^+Treg细胞;B组:DC与T细胞共同培养后删除CIM^+CD25^+Treg细胞;C组:DC与T细胞共同培养时不删除CIM^+CD25^+Treg细胞。D组:对照组。体外应用DC诱导T细胞产生效应细胞CTL,将CTL经鼠尾静脉回输小鼠体内,观察对黑色素瘤的抑瘤效果。结果A、B、c3组对B16黑色素瘤抑瘤率分别为90.89%、92.52%、60.02%,均明显高于对照组(P〈0.05)。删除CIM^+CD25^+Treg细胞的A、B两组抑瘤率优于C组(P〈0.05)。但A、B两组问抑瘤率差异无统计学意义(P〉0.05)。结论删除CIM^+CD25^+Treg细胞可明显提高CTL对B16黑色素瘤的抑瘤效果。 Objective To investigate the role of CD4 + CD25 + regulatm7 T cell (Treg) in cytotox- ic T lymphocyte (CTL) inhibiting B16 melanoma and the mechanism. Methods B16 melanoma cells were injected into subcutaneous tissue under the left shoulder of the C57BL/6 mouse to make the melanoma ani mal models. Then the animal models were irradiated by ^60Co-ray on the total body in order to get a no-mar row lymphocyte deletion (NMLD) state. Eighty C57BL/6 mice were divided into 4 groups: 3 experimental groups and a control group, with 20 mice each. In vitro T cells were induced into CTL with tumor specifici ty. CTL were injected back into the mouse body through the vein in the tail. The changes of tumor volume and tumor weight were observed. Results The tumor inhibition rate in the three experiment groups was 90. 89%, 92. 52% and 60. 02% respectively, which was significantly higher than that in the control group (P 〈0. 05). A significant tumor inhibition was observed in groups A and B with a deletion of CD4 + CD25 + Tregs, in comparison with that in group C with no deletion of Tregs ( P 〈 0. 05 ). But no significant difference was found between groups A and B with deletion of Tregs at different time points ( P 〉 0. 05 ). Conclusion The deletion of CIM + CD25 + Treg could significantly increase the tumor inhibition effect of antigen-specific CTL in melanoma.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2014年第4期771-773,共3页 Chinese Journal of Experimental Surgery
基金 河北省卫生厅重点课题(08120)
关键词 树突状细胞 细胞毒性T细胞 黑色素瘤 抑瘤率 Dendritic cell Cytotoxic T lymphocyte Melanoma Inhibition rate of tumor
  • 相关文献

参考文献9

  • 1Kim DS, Kim DH, Goo B, et al. Immunotherapy of malignant melanoma with tumor lysate-pulsed autologous monocyte-derived dendritic cells [J]. Yonsei Med J,2011,52(6) :990-998.
  • 2王煜,牛洪泉,董芳永,董震,雷霆,薛德麟.树突状细胞疫苗免疫治疗策略[J].中华实验外科杂志,2005,22(6):757-757. 被引量:27
  • 3Ridotfi L, Petrini M, Fiammenghi L, et al. Dendritic cell-based vaccine in advanced melanoma : update of clinical outcome [ J ]. Melanoma Res ,2011,21 (6) :524-529.
  • 4Correll A,Tuettenberg A, Becker C, et al. Increased regulatory T-celI frequencies in patients with advanced melanoma correlate with a gen- erally impaired T-cell responsiveness and are restored after dendritic cell-based vaccination[ J] Exp Dermato1,2010,19 ( 8 ) :213-221.
  • 5王凌云,黄开红,闵军,苏红,朱兆华.胃癌患者外周血调节性T细胞的多种细胞因子水平的检测及其意义[J].中华实验外科杂志,2006,23(11):1375-1377. 被引量:18
  • 6Jacobs JF,Punt C J, Lesterhuis WJ. Dendritic cell vaccination in com- bination with anti-CD25 monoclonal antibody treatment:a phase I/II study in metastatic melanoma patients [ J ]. Clin Cancer Res,2010,16 (20) :5067-5078.
  • 7Barrou B, Thioun N, Gattegnio B, et al. Massive expansion of regulato- ry T-cells following interleukin 2 treatment during a phase I-II dendrit- ic cell-based immunotherapy of metastatic renal cancer [ J ]. Int J On- col,2009,35 ( 3 ) :569-581.
  • 8Bien E, Balcerska A, Adamkiewicz-Drozynska E, et al. Pre-treatment serum levels of interleukin-10, interleukin-12 and their ratio predict response to therapy and probability of event-free and overall survival in childhood soft tissue sarcomas, Hodgkin' s lymphomas and acute lym- phoblastic leukemias [ J]. Clin Biochem ,2009,42 (10) :1144-1157.
  • 9Bacher N, Graulich E, Jonuleit H, et al. Interferon-c abrogates toler- ance induction by human tolerogenic dendritic cells [ Jl. PLoS One, 2011,6(7) :22763.

二级参考文献6

  • 1Akasaki Y,Kikuchi T,Homma S,et al.Antitumor effect of immunizations with fusions of dendritic and glioma cells in a mouse brain tumor model.J Immunother,2001,24:106-113.
  • 2Kikuchi T,Abe T,Ohno T.Effects of glioma cells on maturation of dendritic cells.J Neurooncol,2002,58:125-130.
  • 3王凌云 黄开红 朱兆华 等.胃癌患者PBMCs中CD4^+CD25^+调节T细胞的分选及体外增殖分析[J].中国免疫学杂志,2005,21:73-73.
  • 4Zheng SG, Wang JH, Gray JD, et al. Natural and induced CD4^+ CD25^+ cells educate CD4^+ CD25^- cells to develop suppressive activity: the role of IL-2, TGF-β and IL-10. J Immunol, 2004,172:5213-5221.
  • 5Tanaka H, Tanaka J, Kjaergaard J, et al. Depletion of CD4^+ CD25^+ regulatory cells augments the generation of specific immune T cells in tumor-draining lymph nodes. J Immunother, 2002,25 : 207-217.
  • 6薛德麟,雷霆,董震,董芳永,牛洪泉,厉春玲,张韬,王凯.脑胶质瘤自体疫苗的临床实验研究[J].中华实验外科杂志,2003,20(2):139-140. 被引量:19

共引文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部